The Trump administration withdrew Heidi Overton’s nomination to lead the Food and Drug Administration Tuesday, after Senate Republicans opposed her bid for the agency’s top job. The administration withdrew Heidi Overton’s nomination to lead the FDA amid opposition from Senate Republicans.

CBS News sources said the White House had begun discussing possible replacements, including candidates who could serve as acting commissioner without Senate confirmation. Missouri Republican Sen. Josh Hawley pressed for an administration-promised safety study of mifepristone, while Overton sidestepped questions about how she would handle the study.

According to MS NOW, Some supporters of Health Secretary Robert F. Kennedy Jr.’s Make America Healthy Again initiative also opposed Overton, arguing she would not adequately challenge corporate interests. Overton graduated from the University of New Mexico medical school and earned a doctorate from Johns Hopkins Bloomberg School of Public Health, MS NOW reported.

According to CBS News, CBS reported that FDA Commissioner Marty Makary said in a November 8 statement that tobacco interests pressured him to approve fruit-flavored vapes appealing to children, but he refused. The FDA oversees products that account for roughly 20% of consumer spending, CBS reported.